TaxTMI Login
Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
of 
of 
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
of of 
All News
of of All News
Note
Bookmark
Share
Don't have an account? Register Here
of <h1>Biotech Breakthrough: AI-Powered Oral Molecule Could Revolutionize Obesity Treatment with Targeted Receptor Approach</h1> A biotechnology company announced a significant milestone in its obesity drug discovery program, developing oral small molecule modulators targeting the glucose-dependent insulinotropic polypeptide receptor. Using AI and machine learning platforms, the company designed novel molecules to potentially treat obesity more affordably. The firm is advancing its research toward pre-investigational new drug studies and filing patents for its innovative approach.
TaxTMI 
TaxTMI 
